Crosstalk of AP4 and TGFβ receptor signaling in NSCLC

Tumor Biology

Volumn 36, Issue 1, 2015, Pages 447-452

  Wang, Wei ^a   Wu, Xinyu ^a   Tian, Yu ^b  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b Inner Mongolia Autonomous Region   (China)

Author keywords

Activating protein 4; Non small cell lung cancer; p21; SMAD2; Transforming growth factor

Indexed keywords

PROTEIN P21; SMAD2 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ACTIVATING PROTEIN 4; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1A; REPIN1 PROTEIN, HUMAN; SMAD2 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; LUNG TUMOR; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; TUMOR CELL LINE;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; LUNG NEOPLASMS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR CROSS-TALK; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84925543766     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2674-6     Document Type: Article

References (18)

1. Zarogoulidis K, Zarogoulidis P, Darwiche K, Boutsikou E, Machairiotis N, Tsakiridis K, et al. Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis. 2013;5:S389–96.
2. Mitsudomi T, Suda K, Yatabe Y. Surgery for NSCLC in the era of personalized medicine. Nat Rev Clin Oncol. 2013;10:235–44.
3. Pallis AG, Syrigos KN. Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC. Lung Cancer. 2013;80:120–30.
4. Jung P, Hermeking H. The c-MYC-AP4-p21 cascade. Cell Cycle. 2009;8:982–9.
5. Jung P, Menssen A, Mayr D, Hermeking H. AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci U S A. 2008;105:15046–51.
6. Goc A, Al-Azayzih A, Abdalla M, Al-Husein B, Kavuri S, Lee J, et al. P21 activated kinase-1 (pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor beta expression and enhanced matrix metalloproteinase 9 secretion. J Biol Chem. 2013;288:3025–35.
7. Chiang YA, Shao W, Xu XX, Chernoff J, Jin T. P21-activated protein kinase 1 (Pak1) mediates the cross talk between insulin and beta-catenin on proglucagon gene expression and its ablation affects glucose homeostasis in male C57BL/6 mice. Endocrinology. 2013;154:77–88.
8. Ge Z, Zhang B, Bu X, Wang Y, Xiang L, Tan J. Molecular mechanism of activating protein-4 regulated growth of hepatocellular carcinoma. Tumour Biol. 2014.
9. Massague J. TGFbeta in cancer. Cell. 2008;134:215–30.
10. Xiao X, Gaffar I, Guo P, Wiersch J, Fischbach S, Peirish L, et al. M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci U S A. 2014;111:E1211–20.
11. Yi JJ, Barnes AP, Hand R, Polleux F, Ehlers MD. TGF-beta signaling specifies axons during brain development. Cell. 2010;142:144–57.
12. Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y, et al. TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010;463:676–80.
13. Xiao X, Wiersch J, El-Gohary Y, Guo P, Prasadan K, Paredes J, et al. TGFbeta receptor signaling is essential for inflammation-induced but not beta-cell workload-induced beta-cell proliferation. Diabetes. 2013;62:1217–26.
14. Jeon HS, Jen J. TGF-beta signaling and the role of inhibitory smads in non-small cell lung cancer. J Thorac Oncol. 2010;5:417–9.
15. Baek HJ, Kim SS, da Silva FM, Volpe EA, Evans S, Mishra B, et al. Inactivation of TGF-beta signaling in lung cancer results in increased CDK4 activity that can be rescued by elf. Biochem Biophys Res Commun. 2006;346:1150–7.
16. Vujaskovic Z, Groen HJ. TGF-beta, radiation-induced pulmonary injury and lung cancer. Int J Radiat Biol. 2000;76:511–6.
17. Damstrup L, Rygaard K, Spang-Thomsen M, Skovgaard Poulsen H. Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines. Br J Cancer. 1993;67:1015–21.
18. Heidtmann HH, Havemann K, Schwartz-Albiez R. Regulation of the plasminogen activator system in non-small cell lung cancer cell lines by growth factors EGF, TGF-alpha and TGF-beta. Br J Cancer. 1992;65:154–6.